CLINICAL TRIALS WITH BEPHENIUM HYDROXYNAPHTHOATE AGAINST ANCYLOSTOMA DUODENALE AND OTHER INTESTINAL HELMINTHS.
D000293:Adolescent; D000722:Ancylostoma; D000724:Ancylostomiasis; D000740:Anemia; D000818:Animals; D001196:Ascariasis; D001598:Bephenium Compounds; D001795:Blood Pressure Determination; D002648:Child; D004358:Drug Therapy; D004534:Egypt; D005260:Female; D006376:Helminths; D006529:Hepatomegaly; D006725:Hookworm Infections; D006801:Humans; D007410:Intestinal Diseases; D007411:Intestinal Diseases, Parasitic; D007677:Kidney Function Tests; D008111:Liver Function Tests; D011247:Pregnancy; D012547:Schistosoma; D013163:Splenomegaly; D013750:Tetrachloroethylene; D014116:Toxicology; D014252:Trichostrongyloidiasis; D014257:Trichuriasis; D014839:Vomiting
D001598:Bephenium Compounds; C006739:bephenium hydroxynaphthoate; D013750:Tetrachloroethylene
ADOLESCENCE; ANCYLOSTOMA; ANEMIA; ASCARIASIS; BEPHENIUM COMPOUNDS; BLOOD PRESSURE DETERMINATION; CHILD; DRUG THERAPY; EGYPT; HELMINTHS; HEPATOMEGALY; HOOKWORM INFECTION; INTESTINAL DISEASES, PARASITIC; KIDNEY FUNCTION TESTS; LIVER FUNCTION TESTS; PREGNANCY; SCHISTOSOMA; SPLENOMEGALY; TETRACHLOROETHYLENE; TOXICOLOGIC REPORT; TRICHOSTRONGYLOIDIASIS; TRICHURIASIS; VOMITING